Subscribe to these results:

Upcoming Workshops

For Breast Cancer

  1. Register
  2. Register

For Head and Neck Cancer

  1. Register

For Lung Cancer

For Multiple Myeloma

  1. Register

Past workshops

For All Cancers

    1. Clinical Trials: How They Transform the Treatment of Cancer
    2. Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
    3. Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
    4. Clinical Trials: How They Transform the Treatment of Cancer
    5. Update on Clinical Trials: How They Work
    6. New Perspectives in Clinical Trial Research

For Acute Lymphoblastic Leukemia

    1. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
    2. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    3. Update from the 2021 American Society of Hematology (ASH) Annual Meeting

For Acute Myeloid Leukemia

    1. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
    2. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    3. Update from the 2021 American Society of Hematology (ASH) Annual Meeting

For Basal Cell Cancer

    1. New Perspectives in the Treatment of Advanced Skin Cancer: Advanced Basal Cell and Squamous Cell Cancers

For Bladder Cancer

    1. Bladder Cancer: Treatment UpdatePart I of Life with Bladder Cancer
    2. Bladder Cancer: Treatment UpdatesPart I of Life with Bladder Cancer

For Bone Cancer

    1. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches

For Brain Cancer

    1. Highlights from the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting: Unite and Conquer: Accelerating Progress TogetherPart I of Your Guide to the Latest Cancer Research and Treatment

For Breast Cancer

    1. Updates from the 45th Annual San Antonio Breast Cancer Symposium on Triple Negative Breast Cancer
    2. The Benefits of Clinical Trials for Triple Negative Breast Cancer
    3. Metastatic Triple Negative Breast CancerPart I of Living with Metastatic Triple Negative Breast Cancer
    4. Metastatic Breast Cancer: Treatment Updates
    5. HER2-Positive Metastatic Breast Cancer: What’s New in Treatment & Quality-of-Life
    6. The Role of Radiation Therapy in the Treatment of Breast Cancer
    7. The Benefits of Clinical Trials for Triple Negative Breast Cancer
    8. HER2-Positive Metastatic Breast Cancer: New Therapies
    9. Metastatic Breast Cancer: Treatment Updates
    10. Highlights from the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting: Unite and Conquer: Accelerating Progress TogetherPart I of Your Guide to the Latest Cancer Research and Treatment
    11. The Benefits of Clinical Trials for Triple Negative Breast Cancer

For Chronic Lymphocytic Leukemia

    1. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
    2. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    3. Chronic Lymphocytic Leukemia: Current Treatment PerspectivesPart II of Living with Chronic Lymphocytic Leukemia
    4. Update from the 2021 American Society of Hematology (ASH) Annual Meeting

For Chronic Myelogenous Leukemia

    1. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
    2. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    3. Update from the 2021 American Society of Hematology (ASH) Annual Meeting

For Colorectal Cancer

    1. Advances in the Treatment of Colorectal Cancer
    2. Colorectal Cancer Treatment: Progress and Advances
    3. Colorectal Cancer Treatment: Progress & Advances
    4. Highlights from the 2021 American Society of Clinical Oncology (ASCO) Annual MeetingPart II of Equity. Every Patient. Every Day. Everywhere.

For Cutaneous T-Cell Lymphoma

    1. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
    2. Waldenstrom’s Macroglobulinemia (WM): Treatment Progress
    3. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    4. Update from the 2021 American Society of Hematology (ASH) Annual Meeting

For Diffuse Large B-Cell Lymphoma

    1. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
    2. Waldenstrom’s Macroglobulinemia (WM): Treatment Progress
    3. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    4. Diffuse Large B-Cell Lymphoma (DLBCL) Updates
    5. Update from the 2021 American Society of Hematology (ASH) Annual Meeting

For Follicular Lymphoma

    1. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
    2. Waldenstrom’s Macroglobulinemia (WM): Treatment Progress
    3. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    4. Update from the 2021 American Society of Hematology (ASH) Annual Meeting

For Glioblastoma

    1. Highlights from the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting: Unite and Conquer: Accelerating Progress TogetherPart I of Your Guide to the Latest Cancer Research and Treatment

For Head and Neck Cancer

    1. Oral, Head & Neck Cancer: Treatment Update
    2. Highlights from the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting: Unite and Conquer: Accelerating Progress TogetherPart I of Your Guide to the Latest Cancer Research and Treatment

For Hodgkin Lymphoma

    1. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
    2. Waldenstrom’s Macroglobulinemia (WM): Treatment Progress
    3. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    4. Update from the 2021 American Society of Hematology (ASH) Annual Meeting

For Leukemia

    1. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
    2. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    3. Chronic Lymphocytic Leukemia: Current Treatment PerspectivesPart II of Living with Chronic Lymphocytic Leukemia
    4. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
    5. Highlights from the 2021 American Society of Clinical Oncology (ASCO) Annual MeetingPart II of Equity. Every Patient. Every Day. Everywhere.

For Liver Cancer

    1. Liver Cancer: Treatment Updates

For Lung Cancer

    1. What’s New in Diagnostic Technologies for People Living with Small Cell Lung CancerPart II of Living with Small Cell Lung Cancer
    2. Genomic Testing and Current Trends in the Treatment of Non-Small Cell Lung CancerPart III of Living with Non-Small Cell Lung Cancer
    3. Highlights from the 2021 American Society of Clinical Oncology (ASCO) Annual MeetingPart II of Equity. Every Patient. Every Day. Everywhere.

For Lymphoma

    1. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
    2. Waldenstrom’s Macroglobulinemia (WM): Treatment Progress
    3. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    4. Diffuse Large B-Cell Lymphoma (DLBCL) Updates
    5. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
    6. Highlights from the 2021 American Society of Clinical Oncology (ASCO) Annual MeetingPart II of Equity. Every Patient. Every Day. Everywhere.

For Mantle Cell Lymphoma

    1. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
    2. Waldenstrom’s Macroglobulinemia (WM): Treatment Progress
    3. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    4. Update from the 2021 American Society of Hematology (ASH) Annual Meeting

For Marginal Zone Lymphoma

    1. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
    2. Waldenstrom’s Macroglobulinemia (WM): Treatment Progress
    3. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    4. Update from the 2021 American Society of Hematology (ASH) Annual Meeting

For Melanoma

    1. Highlights from the 2021 American Society of Clinical Oncology (ASCO) Annual MeetingPart II of Equity. Every Patient. Every Day. Everywhere.

For Mesothelioma

    1. Mesothelioma: Innovative Treatment Options
    2. Mesothelioma: Innovative Treatment Options

For Metastatic Breast Cancer

    1. Updates from the 45th Annual San Antonio Breast Cancer Symposium on Triple Negative Breast Cancer
    2. Metastatic Triple Negative Breast CancerPart I of Living with Metastatic Triple Negative Breast Cancer
    3. Metastatic Breast Cancer: Treatment Updates
    4. HER2-Positive Metastatic Breast Cancer: What’s New in Treatment & Quality-of-Life
    5. The Role of Radiation Therapy in the Treatment of Breast Cancer
    6. The Benefits of Clinical Trials for Triple Negative Breast Cancer
    7. HER2-Positive Metastatic Breast Cancer: New Therapies
    8. Metastatic Breast Cancer: Treatment Updates
    9. Highlights from the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting: Unite and Conquer: Accelerating Progress TogetherPart I of Your Guide to the Latest Cancer Research and Treatment

For Multiple Myeloma

    1. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
    2. Progress in the Treatment of Multiple Myeloma
    3. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    4. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
    5. Progress in the Treatment of Multiple Myeloma

For Myelodysplastic Syndromes

    1. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    2. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
    3. Highlights from the 2021 American Society of Clinical Oncology (ASCO) Annual MeetingPart II of Equity. Every Patient. Every Day. Everywhere.

For Myeloproliferative Neoplasms

    1. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
    2. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    3. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
    4. Highlights from the 2021 American Society of Clinical Oncology (ASCO) Annual MeetingPart II of Equity. Every Patient. Every Day. Everywhere.

For Non-Hodgkin Lymphoma

    1. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
    2. Waldenstrom’s Macroglobulinemia (WM): Treatment Progress
    3. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    4. Update from the 2021 American Society of Hematology (ASH) Annual Meeting

For Ovarian Cancer

    1. Highlights from the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting: Unite and Conquer: Accelerating Progress TogetherPart I of Your Guide to the Latest Cancer Research and Treatment

For Pancreatic Cancer

    1. Highlights from the 2021 American Society of Clinical Oncology (ASCO) Annual MeetingPart II of Equity. Every Patient. Every Day. Everywhere.

For Peripheral T-Cell Lymphoma

    1. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
    2. Waldenstrom’s Macroglobulinemia (WM): Treatment Progress
    3. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    4. Update from the 2021 American Society of Hematology (ASH) Annual Meeting

For Prostate Cancer

    1. Highlights from the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting: Unite and Conquer: Accelerating Progress TogetherPart I of Your Guide to the Latest Cancer Research and Treatment

For Sarcoma

    1. Highlights from the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting: Unite and Conquer: Accelerating Progress TogetherPart I of Your Guide to the Latest Cancer Research and Treatment

For Skin Cancer

    1. New Perspectives in the Treatment of Advanced Skin Cancer: Advanced Basal Cell and Squamous Cell Cancers

For Small Lymphocytic Lymphoma

    1. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
    2. Waldenstrom’s Macroglobulinemia (WM): Treatment Progress
    3. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    4. Update from the 2021 American Society of Hematology (ASH) Annual Meeting

For Squamous Cell Cancer

    1. New Perspectives in the Treatment of Advanced Skin Cancer: Advanced Basal Cell and Squamous Cell Cancers

For Triple Negative Breast Cancer

    1. Updates from the 45th Annual San Antonio Breast Cancer Symposium on Triple Negative Breast Cancer
    2. The Benefits of Clinical Trials for Triple Negative Breast Cancer
    3. Metastatic Triple Negative Breast CancerPart I of Living with Metastatic Triple Negative Breast Cancer
    4. Metastatic Breast Cancer: Treatment Updates
    5. HER2-Positive Metastatic Breast Cancer: What’s New in Treatment & Quality-of-Life
    6. The Role of Radiation Therapy in the Treatment of Breast Cancer
    7. The Benefits of Clinical Trials for Triple Negative Breast Cancer
    8. HER2-Positive Metastatic Breast Cancer: New Therapies
    9. Metastatic Breast Cancer: Treatment Updates
    10. Highlights from the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting: Unite and Conquer: Accelerating Progress TogetherPart I of Your Guide to the Latest Cancer Research and Treatment
    11. The Benefits of Clinical Trials for Triple Negative Breast Cancer

For Waldenstrom’s Macroglobulinemia

    1. Waldenstrom’s Macroglobulinemia (WM): Treatment Progress
Back to Top
Terms of Use and Privacy Policy

By using our website, you agree to our recently updated Privacy Policy . Here you can read more about our use of cookies which help us make continuous improvements to our website. Privacy Policy.